Medical Marijuana, Inc. Investment Company AXIM® Biotechnologies Expands Research Division and Announces Dr. Sergei Svarovsky as Chief Scientific Officer of Subsidiary Sapphire Biotech

Medical Marijuana, Inc. Investment Company AXIM® Biotechnologies Expands Research Division and Announces Dr. Sergei Svarovsky as Chief Scientific Officer of Subsidiary Sapphire Biotech

SAN DIEGO, May 28, 2020 /PRNewswire/ — Medical Marijuana, Inc.. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United … Read More…

Excerpt only …
READ MORE BELOW
Source : CANNANNEW REPORT
Link to original : Medical Marijuana, Inc. Investment Company AXIM® Biotechnologies Expands Research Division and Announces Dr. Sergei Svarovsky as Chief Scientific Officer of Subsidiary Sapphire Biotech
reposted by Cannabis News World

This site uses Akismet to reduce spam. Learn how your comment data is processed.